SCHEMBL844937

SCHEMBL844937

O=C1CNCCN1c1ccc2ccccc2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.59
ALDH1A1 P00352 4/20 0.59
CYP3A4 P08684 2/20 0.59
HSD17B10 Q99714 2/20 0.59
HTR3E A5X5Y0 2/20 0.59
HTR3B O95264 2/20 0.59
CYP1A2 P05177 2/20 0.59
HTR3A P46098 2/20 0.59
HTR3D Q70Z44 2/20 0.59
HTR3C Q8WXA8 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
USP2 O75604 1/20 0.59
ADRB1 P08588 1/20 0.59
HTR1A P08908 1/20 0.59
HTR2C P28335 1/20 0.59
MAPK1 P28482 1/20 0.59
SLC6A4 P31645 1/20 0.59
HTR7 P34969 1/20 0.59
HTT P42858 1/20 0.59
HTR6 P50406 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3781498 0.80 KDM4E (0.55) KDM4EALDH1A1CYP3A4HSD17B10HTR3E
SCHEMBL14894663 0.79 HRH3 (0.50) KDM4EALDH1A1CYP3A4HSD17B10HTR3E
SCHEMBL16124972 0.78 ALDH1A1 (0.39) KDM4EALDH1A1CYP3A4HSD17B10HTR3E
SCHEMBL6918242 0.75 KDM4E (0.81) KDM4EALDH1A1CYP3A4HSD17B10HTR3E
SCHEMBL24265517 0.75 ALOX5 (0.50) ALDH1A1HTR3EHTR3BHTR3AHTR3D
SCHEMBL29574338 0.75 ALOX5 (0.50) ALDH1A1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5795727 0.75 HTR3E (0.58) KDM4EALDH1A1CYP3A4HSD17B10HTR3E
Quipazine SCHEMBL322181 0.74 KDM4E (1.00) KDM4EALDH1A1CYP3A4HSD17B10HTR3E
SCHEMBL27329251 0.74 RAB9A (0.53) KDM4EALDH1A1HSD17B10CYP1A2TDP1
SCHEMBL1161095 0.74 PLD1 (0.56) ALDH1A1CYP3A4HSD17B10CYP1A2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432784-A1 FUSED BICYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS UCB Pharma, S.A. (BE) 2012-03-28 EP disclosed
WO-2010133836-A1 FUSED BICYCLIC PYRAZOLE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2010-11-25 WO disclosed